Physician profile
Krystyna Gal
NPI 1588964357
$4,192.12
in general payments reported to CMS, 2019-2025
23 companies · $579 in 2025
The $579 reported for 2025 was more than what 75% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $292 · 2021: $848 · 2022: $1,047 · 2023: $735 · 2024: $533 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,847.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $951.36 | 2019-2025 | Odactra, Grastek, Ragwitek |
| Genzyme Corporation | $501.36 | 2019-2025 | |
| Stryker Corporation | $454.97 | 2020-2025 | Xpress Loprofile, Audion Et Dilation System, Clarifix |
| Regeneron Healthcare Solutions, INC. | $366.42 | 2020-2025 | Dupixent |
| Smith+Nephew, INC. | $264.71 | 2023-2025 | Tula, Halo |
| Glaxosmithkline, LLC. | $240.89 | 2021-2025 | Nucala |
| Acclarent, INC | $229.57 | 2019-2021 | |
| Aerin Medical INC. | $204.67 | 2022-2025 | |
| Optinose US, INC. | $184.77 | 2022-2025 | |
| Abbvie INC. | $152.95 | 2022-2024 | |
| Medtronic, INC. | $135.80 | 2023-2025 | Pteye Parathyroid Detection System, Propel, Nuvent |
| Intersect Ent, INC. | $92.10 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $90.04 | 2025 | Voquezna |
| Inspire Medical Systems, INC. | $48.78 | 2023 | Inspire |
| Integra Lifesciences Corporation | $44.84 | 2022-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $42.71 | 2020-2022 | |
| Checkpoint Surgical, INC | $36.43 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $33.55 | 2021 | |
| Depuy Synthes Sales INC. | $30.86 | 2019 | |
| Hikma Pharmaceuticals USA | $30.52 | 2023 | Ryaltris |
| Tactile Systems Technology INC | $19.17 | 2019 | |
| Hologic Sales and Service, LLC | $18.00 | 2023 | Coolseal Generator |
| Livanova USA, INC. | $17.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystyna Gal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.